The novel therapy of the medication represents a major development in the management of type 2 diabetes. Unlike existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide925628.bluxeblog.com/74479223/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment